Connie Kasari1, Ann Kaiser2, Kelly Goods3, Jennifer Nietfeld2, Pamela Mathy4, Rebecca Landa5, Susan Murphy6, Daniel Almirall6. 1. University of California-Los Angeles (UCLA) Semel Institute for Neuroscience and Human Behavior. Electronic address: kasari@gseis.ucla.edu. 2. Vanderbilt University. 3. First Five Los Angeles. 4. Speech, Language and Hearing Clinic, University of Utah. 5. Kennedy Krieger Institute. 6. University of Michigan.
Abstract
OBJECTIVE: This study tested the effect of beginning treatment with a speech-generating device (SGD) in the context of a blended, adaptive treatment design for improving spontaneous, communicative utterances in school-aged, minimally verbal children with autism. METHOD: A total of 61 minimally verbal children with autism, aged 5 to 8 years, were randomized to a blended developmental/behavioral intervention (JASP+EMT) with or without the augmentation of a SGD for 6 months with a 3-month follow-up. The intervention consisted of 2 stages. In stage 1, all children received 2 sessions per week for 3 months. Stage 2 intervention was adapted (by increased sessions or adding the SGD) based on the child's early response. The primary outcome was the total number of spontaneous communicative utterances; secondary measures were the total number of novel words and total comments from a natural language sample. RESULTS: Primary aim results found improvements in spontaneous communicative utterances, novel words, and comments that all favored the blended behavioral intervention that began by including an SGD (JASP+EMT+SGD) as opposed to spoken words alone (JASP+EMT). Secondary aim results suggest that the adaptive intervention beginning with JASP+EMT+SGD and intensifying JASP+EMT+SGD for children who were slow responders led to better posttreatment outcomes. CONCLUSION:Minimally verbal school-aged children can make significant and rapid gains in spoken spontaneous language with a novel, blended intervention that focuses on joint engagement and play skills and incorporates an SGD. Future studies should further explore the tailoring design used in this study to better understand children's response to treatment. Clinical trial registration information-Developmental and Augmented Intervention for Facilitating Expressive Language (CCNIA); http://clinicaltrials.gov/; NCT01013545.
RCT Entities:
OBJECTIVE: This study tested the effect of beginning treatment with a speech-generating device (SGD) in the context of a blended, adaptive treatment design for improving spontaneous, communicative utterances in school-aged, minimally verbal children with autism. METHOD: A total of 61 minimally verbal children with autism, aged 5 to 8 years, were randomized to a blended developmental/behavioral intervention (JASP+EMT) with or without the augmentation of a SGD for 6 months with a 3-month follow-up. The intervention consisted of 2 stages. In stage 1, all children received 2 sessions per week for 3 months. Stage 2 intervention was adapted (by increased sessions or adding the SGD) based on the child's early response. The primary outcome was the total number of spontaneous communicative utterances; secondary measures were the total number of novel words and total comments from a natural language sample. RESULTS: Primary aim results found improvements in spontaneous communicative utterances, novel words, and comments that all favored the blended behavioral intervention that began by including an SGD (JASP+EMT+SGD) as opposed to spoken words alone (JASP+EMT). Secondary aim results suggest that the adaptive intervention beginning with JASP+EMT+SGD and intensifying JASP+EMT+SGD for children who were slow responders led to better posttreatment outcomes. CONCLUSION: Minimally verbal school-aged children can make significant and rapid gains in spoken spontaneous language with a novel, blended intervention that focuses on joint engagement and play skills and incorporates an SGD. Future studies should further explore the tailoring design used in this study to better understand children's response to treatment. Clinical trial registration information-Developmental and Augmented Intervention for Facilitating Expressive Language (CCNIA); http://clinicaltrials.gov/; NCT01013545.
Authors: Anett Kaale; Morten W Fagerland; Egil W Martinsen; Lars Smith Journal: J Am Acad Child Adolesc Psychiatry Date: 2013-10-17 Impact factor: 8.829
Authors: Junko Matsuzaki; Emily S Kuschner; Lisa Blaskey; Luke Bloy; Mina Kim; Matthew Ku; James Christopher Edgar; David Embick; Timothy P L Roberts Journal: Autism Res Date: 2019-05-28 Impact factor: 5.216
Authors: Nancy C Brady; Susan Bruce; Amy Goldman; Karen Erickson; Beth Mineo; Bill T Ogletree; Diane Paul; Mary Ann Romski; Rose Sevcik; Ellin Siegel; Judith Schoonover; Marti Snell; Lorraine Sylvester; Krista Wilkinson Journal: Am J Intellect Dev Disabil Date: 2016-03
Authors: Grace W Gengoux; Kari L Berquist; Emma Salzman; Salena Schapp; Jennifer M Phillips; Thomas W Frazier; Mendy B Minjarez; Antonio Y Hardan Journal: J Autism Dev Disord Date: 2015-09
Authors: Nancy C Brady; Holly L Storkel; Paige Bushnell; R Michael Barker; Kate Saunders; Debby Daniels; Kandace Fleming Journal: Am J Speech Lang Pathol Date: 2015-08 Impact factor: 2.408